Search results for " hemoglobin"

showing 10 items of 204 documents

National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys…

2011

Summary Background Data for trends in glycaemia and diabetes prevalence are needed to understand the effects of diet and lifestyle within populations, assess the performance of interventions, and plan health services. No consistent and comparable global analysis of trends has been done. We estimated trends and their uncertainties in mean fasting plasma glucose (FPG) and diabetes prevalence for adults aged 25 years and older in 199 countries and territories. Methods We obtained data from health examination surveys and epidemiological studies (370 country-years and 2·7 million participants). We converted systematically between different glycaemic metrics. For each sex, we used a Bayesian hier…

GerontologyAdultBlood GlucoseMalemedicine.medical_specialtyLatin AmericansPsychological interventionGlobal HealthBody Mass IndexSettore MED/43 - Medicina LegaleDiabetes mellitusEpidemiologymedicineGlobal healthDiabetes MellitusPrevalencePopulation growthHumansHemoglobin A GlycosylatedGlycated Hemoglobinbusiness.industryPublic healthDiabetes MellituGeneral MedicineFastingHealth Surveymedicine.diseaseHealth SurveysWorld HealthFemalebusinessBody mass indexDemographyHumanLancet (London, England)
researchProduct

Low Hemoglobin Levels and the Onset of Cognitive Impairment in Older People: The PRO.V.A. Study

2016

Low hemoglobin (Hb) levels are attracting interest as a risk factor for cognitive impairment, but with contrasting evidence emerging from the current literature. The aim of our work was to investigate the relationship between baseline serum Hb levels and the incidence of cognitive impairment in older people over a follow-up of 4.4 years. Our study considered a sample of 1227 elderly subjects cognitively intact at baseline, enrolled under the Progetto Veneto Anziani (Pro.V.A.) among 3099 screened subjects. For all participants, we measured serum Hb levels on blood samples; incident cognitive impairment was defined as a Mini Mental State Examination (MMSE) score <24 and confirmed by geriat…

GerontologyMalesex differencesAgingmedicine.medical_specialtyAnemiaelderlyNOhemoglobin concentration03 medical and health sciencesHemoglobins0302 clinical medicineInternal medicinemedicineDementiaHumansCognitive Dysfunction030212 general & internal medicineHemoglobinRisk factorCognitive impairmentAgedcognitive impairmentAged 80 and overSex CharacteristicsMini–Mental State Examinationmedicine.diagnostic_testbusiness.industryIncidence (epidemiology)Incidencemedicine.diseaseanemiaConfidence intervalanemia; cognitive impairment; dementia; elderly; hemoglobin concentration; sex differencesFemaleGeriatrics and Gerontologybusiness030217 neurology & neurosurgerySex characteristicsFollow-Up Studiesdementia
researchProduct

Interactive Process Mining in Type 2 Diabetes Mellitus

2020

This chapter is a descriptive use case of the Interactive Process Mining paradigm in one of the most significant problems of healthcare in relation to the management of chronic conditions, Type 2 Diabetes Mellitus. The chapter firstly performs a comprehensive description of the disease, its origins, evolution and standard of care, to thereafter adapt the concepts of Interactive Process Mining to trigger big quantities of heterogeneous observational data into actionable information for patient’s evaluations. The use case is focused in the analysis of Glycated Hemoglobin, a major indicator of blood glucose levels and a key factor in the management of the disease. The chapter is a preliminary …

GerontologyRelation (database)business.industryType 2 Diabetes MellitusProcess miningDiseasemedicine.diseasechemistry.chemical_compoundchemistryDiabetes mellitusHealth careMedicineObservational studyGlycated hemoglobinbusiness
researchProduct

Risk of progression to diabetes and mortality in older people with prediabetes: The English longitudinal study on ageing

2022

Abstract Aims Prediabetes is used to identify people at increased risk for diabetes. However, the importance of prediabetes in older populations is still poorly explored. Therefore, we aimed to investigate the prevalence of prediabetes, based on either glycated haemoglobin (HbA1c) levels or fasting glucose (FG) levels, or both and the progression of prediabetes to diabetes or to mortality in older participants of the English Longitudinal Study on Ageing. Materials and methods Prediabetes was categorized based on HbA1c levels (5.7%–6.4%) and/or FG levels (5.6–7.0 mmol/L). Information regarding mortality and incident diabetes were recorded during follow-up period of 10 years. Results In 2027 …

Glycated HemoglobinBlood GlucoseMaleAgingGlycated Hemoglobin AdiabetesEnglish Longitudinal Study on Ageing (ELSA)prediabetesGeneral MedicineEnglish Longitudinal Study on Ageing (ELSA); diabetes; older people; prediabetes; Aged; Aging; Blood Glucose; Female; Glycated Hemoglobin A; Humans; Longitudinal Studies; Male; Risk Factors; Prediabetic Stateprediabetes diabetes older people English Longitudinal Study on Ageing (ELSA)older peoplePrediabetic StateRisk FactorsHumansFemaleLongitudinal StudiesGeriatrics and GerontologyResearch PaperAgedAge and Ageing
researchProduct

Behavioral medicine interventions in diabetes.

2010

Poor glycemic control is prevalent in the majority of patients with diabetes and has a strong impact on medical as well as psychological outcomes. Psychological and behavioral variables are of particular interest, as the patients themselves are the most determining factor of treatment success. Consequently, a wide range of behavioral medicine interventions are aimed at improvement in diabetes self-management, coping strategies, blood glucose awareness, and stress reduction. This review provides an overview of randomized controlled trials (RCTs) published in the past 18 months (from March 2008 to September 2009) that evaluated behavioral medicine interventions in patients with diabetes. The …

Glycated Hemoglobinbusiness.industryHealth BehaviorPsychological interventionMEDLINEHealth Promotionmedicine.diseaseSelf CarePsychiatry and Mental healthHealth promotionPatient Education as TopicDiabetes mellitusBehavioral medicineSelf careDiabetes MellitusMedicineHumansPatient ComplianceHealth behaviorbusinessGlycemicClinical psychologyCurrent opinion in psychiatry
researchProduct

A well-oxygenated cells environment may help to fight against protein glycation

2010

Normoglycemic Wistar rats' Glycated Hemoglobin Levels (GHL) showed a time-dependent difference between control groups and those exposed to regular inhalation of peroxidizing extracts of turpentine. These extracts were able to optimize the oxygen permeation at the cellular level during and subsequently to a breathing session. The more the rats breathed turpentine peroxidized vapor, the lower their GHL was. This study was designed to confirm, in ex-vivo blood samples, the impact of peroxidizing extract on the GHL.Red blood cells were separated from plasmas by centrifugation. Plasmas were treated by peroxidizing and non-peroxidizing turpentine vapor or untreated (control), then combined with w…

Glycated Hemoglobinmedicine.medical_specialtyErythrocytesInhalationTerpenesChemistryPublic Health Environmental and Occupational HealthTurpentineGeneral MedicinePharmacologyCellular levelRatsSurgeryOxygenTerpenechemistry.chemical_compoundInhalationmedicineAnimalsGlycated hemoglobinRats WistarProtein glycationInternational Journal of Occupational Medicine and Environmental Health
researchProduct

Ligation Tunes Protein Reactivity in an Ancient Haemoglobin: Kinetic Evidence for an Allosteric Mechanism in Methanosarcina acetivorans Protoglobin

2012

Abstract: Protoglobin from Methanosarcina acetivorans (MaPgb) is a dimeric globin with peculiar structural properties such as a completely buried haem and two orthogonal tunnels connecting the distal cavity to the solvent. CO binding to and dissociation from MaPgb occur through a biphasic kinetics. We show that the heterogenous kinetics arises from binding to (and dissociation from) two tertiary conformations in ligation-dependent equilibrium. Ligation favours the species with high binding rate (and low dissociation rate). The equilibrium is shifted towards the species with low binding (and high dissociation) rates for the unliganded molecules. A quantitative model is proposed to describe t…

HEME ENVIRONMENTStereochemistrySILICA-GELSArchaeal ProteinsAllosteric regulationKineticsBiophysicslcsh:MedicinePlasma protein bindingBiochemistryDissociation (chemistry)HemoglobinsAllosteric RegulationBINDINGINTERNAL HYDROPHOBIC CAVITIESMoleculeGlobinFerrous CompoundsMethanosarcina acetivoransSettore BIO/10lcsh:ScienceBiologyT STATE HEMOGLOBINCarbon MonoxideMultidisciplinaryPhotolysisbiologyChemistryPhysicslcsh:RProteinsMethanosarcinabiology.organism_classificationRecombinant ProteinsEnzymesGlobinsKineticsOXYGEN-AFFINITYBiochemistryMethanosarcinaARABIDOPSIS-THALIANAlcsh:QGLOBIN-COUPLED SENSORSHuman medicineProtein MultimerizationLIGAND MIGRATIONNEUROGLOBINResearch ArticleProtein Binding
researchProduct

Insulin degludec and insulin glargine 300 U/mL: Which of these two insulins causes less hypoglycemia?

2019

The interesting article by Yamabe et al.1 showed, using continuous glucose monitoring, that insulin degludec (I‐Deg) was associated with a high percentage of time with nocturnal hypoglycemia than with insulin glargine 300 U/mL (I‐G300; P = 0.02). However, we observe that some possible confounding factors might have influenced the results, such as differences in concomitant medications, use of the same titration protocol for both kinds of insulin or differences in glucose levels. This is also a recurrent problem in clinical trials, which sometime produce conflicting results. In fact, the study of Yamabe et al. is partly in agreement with some recently published clinical trials that gave diff…

Insulin degludecBlood Glucosemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentdiabetes insulin clinical trials hypoglicemiaInsulinsInsulin GlargineHypoglycemiaDiseases of the endocrine glands. Clinical endocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsLetters to the EditorLetter to the EditorGlycated HemoglobinInsulin glarginebusiness.industryInsulinBlood Glucose Self-Monitoringnutritional and metabolic diseasesGeneral Medicinemedicine.diseaseRC648-665HypoglycemiaClinical trialInsulin Long-ActingEndocrinologyDiabetes Mellitus Type 2businessmedicine.drug
researchProduct

Continuous glucose monitoring use and glucose variability in very young children with type 1 diabetes (VibRate): A multinational prospective observat…

2021

While data on the efficacy and safety of continuous glucose monitoring (CGM) exist across a broad age spectrum, it is limited in very young children with type 1 diabetes (T1D). We aimed to assess real-world data in this high-risk population, focusing on glycemic variability and metrics beyond HbA1c. A 12-month multi-national, prospective, observational, registry-based cohort study in children with T1D aged 1-7 years compared glucose control using real-time CGM and using fingerstick blood glucose monitoring (BGM) alone. The prespecified primary endpoint was a difference in coefficient of variation (CV) between the CGM users and BGM-only cohort. Among 227 individuals using insulin pumps (42% …

Insulin pumpBlood GlucosePediatricsmedicine.medical_specialtyendocrine system diseasesFingerstickEndocrinology Diabetes and MetabolismPopulationChildren; Continuous glucose monitoring; Insulin pump; Toddlers; Type 1 diabetesCohort StudiesHDE END PEDEndocrinologyInsulin Infusion SystemsInternal MedicinemedicineHumansHypoglycemic AgentsInsulinInsulin pumpeducationChildChildrenContinuous glucose monitoringchildren; continuous glucose monitoring; insulin pump; toddlers; type 1 diabetesGlycemicBlood glucose monitoringGlycated HemoglobinToddlerseducation.field_of_studyType 1 diabetesmedicine.diagnostic_testEndocrinology; Metabolismbusiness.industryBlood Glucose Self-Monitoringnutritional and metabolic diseasesDiabetes type 1medicine.diseaseType 1 diabetesDiabetes Mellitus Type 1GlucoseChild PreschoolCohortbusinessCohort studyDiabetes Obesity & Metabolism
researchProduct

Glycemic Outcome Associated With Insulin Pump and Glucose Sensor Use in Children and Adolescents With Type 1 Diabetes. Data From the International Pe…

2021

OBJECTIVE Insulin delivery methods, glucose-monitoring modalities, and related outcomes were examined in a large, international, diverse cohort of children and adolescents with type 1 diabetes from the Better Control in Pediatric and Adolescent Diabetes: Working to Create Centers of Reference (SWEET) -Registry. RESEARCH DESIGN AND METHODS Participants with type 1 diabetes of >= 1 year, aged <= 18 years, and who had documented pump or sensor usage during the period August 2017-July 2019 were stratified into four categories: injections-no sensor (referent); injections + sensor; pump-no sensor; and pump + sensor. HbA(1c) and proportion of patients with diabetic ketoacidosis (DKA) or severe hyp…

Insulin pumpKetoacidosisBlood Glucosemedicine.medical_specialtyDiabetic ketoacidosisAdolescentEndocrinology Diabetes and MetabolismDpv030209 endocrinology & metabolismHypoglycemia03 medical and health sciences0302 clinical medicineInsulin Infusion SystemsDiabetes mellitusInternal medicineInternal MedicinemedicineHumansHypoglycemic AgentsInsulin030212 general & internal medicineRegistriesChildGlycemicAdvanced and Specialized NursingGlycated HemoglobinType 1 diabetesbusiness.industryBlood Glucose Self-Monitoringmedicine.diseaseQualityHypoglycemiaKetoacidosisDiabetes Mellitus Type 1CohortTherapybusinessDiabetes Care
researchProduct